Successful Development of Materials for PCR Diagnostic Kits and Adoption by Multiple Manufacturers
First written in FY2020. 5 of 13 entries say "Worsened", first in FY2022-Q1. Latest entry: FY2024-Q3.
No other company in this theme has enough history to compare yet.
- FY2024-Q3SoftenedAnnual report
「Demand for materials used in PCR diagnostic kits supplied by a subsidiary remained weak, but increased demand for OLED materials, mainly in the smartphone display sector, together with the positive effect of foreign exchange movements on revenue, resulted in a substantial increase in revenue for the OLED materials business as a whole.」
Although demand for materials for PCR diagnostic kits remains sluggish, the business as a whole recorded a substantial increase in revenue, representing a weaker impact than the previous description of a substantial decline in demand and a decline in business revenue. - FY2024-Q2WorsenedAnnual report
「Although demand for materials used in PCR diagnostic kits supplied by a subsidiary declined substantially in the post-COVID period, demand for OLED materials, mainly for smartphones, continued to increase, resulting in a substantial increase in revenue for the OLED materials business as a whole.」
Demand for materials for PCR diagnostic kits remains sluggish, and the description has become more pronounced, changing from declining demand in the previous quarter to a substantial post-COVID decline. - FY2023-Q3WorsenedAnnual report
「Demand related to COVID-19 in the previous year for materials used in PCR diagnostic kits supplied by a subsidiary declined substantially, but demand for OLED panels in the smartphone display sector continued to increase, leaving revenue for the OLED materials business as a whole at the same level as the previous year.」
Demand for materials for PCR diagnostic kits changed from stable sales throughout the previous fiscal year to a substantial decline. However, increased demand for OLED panels kept the business as a whole at approximately the same level as in the previous year. - FY2023-Q2WorsenedAnnual report
「Demand for OLED panels in the smartphone display sector continued to increase, but demand for materials used in PCR diagnostic kits supplied by a subsidiary declined substantially from the previous year's demand related to COVID-19, resulting in lower revenue for the OLED materials business as a whole.」
A substantial decline in demand for materials for PCR diagnostic kits after the special demand was reported, resulting in a decline in revenue for the OLED materials business as a whole, including those materials. - FY2023-Q1WorsenedAnnual report
「Demand for materials used in PCR diagnostic kits supplied by a subsidiary declined, but demand for OLED panels in the smartphone display sector continued to increase, leaving revenue for the OLED materials business as a whole at the same level as the previous year.」
For materials for PCR diagnostic kits, which had sold steadily throughout the previous fiscal year, declining demand was reported for the current quarter. - FY2022RestatedAnnual report
「Special demand for materials for PCR diagnostic kits at our subsidiary subsided in the first quarter of the previous fiscal year, but stable sales continued throughout the current consolidated fiscal year」
The company reported that materials for PCR diagnostic kits continued to sell steadily throughout the fiscal year after the special demand subsided. - FY2022-Q3RestatedAnnual report
「Special demand for materials for PCR diagnostic kits at our subsidiary subsided in the first quarter of the previous fiscal year, but stable sales have continued」
Stable sales of materials for PCR diagnostic kits have continued even after the special demand in the previous fiscal year subsided. - FY2022-Q2SoftenedAnnual report
「In the OLED materials business, special demand for materials for PCR diagnostic kits at our subsidiary subsided in the first quarter of the previous fiscal year, but stable sales have continued.」
The description changed from a substantial increase in revenue driven by special demand in the previous fiscal year to continued stable sales after the special demand had subsided. - FY2022-Q1WorsenedAnnual report
「Meanwhile, at our subsidiary, materials for PCR diagnostic kits developed as an application of OLED materials levelled off after the special demand related to COVID-19 in the previous fiscal year, resulting in a substantial decline in revenue for the OLED materials business as a whole.」
The materials for PCR diagnostic kits levelled off after the special demand generated by adoption by multiple manufacturers in the previous fiscal year, resulting in a substantial decline in revenue for the OLED materials business as a whole, including those materials. - FY2021-Q3A slight recovery from the decline in sales volumeAnnual report
「Sales volume had declined during the second quarter due to intensifying competition, but has recently shown signs of a slight recovery as infections spread again globally.」
The description changed from a decline in sales volume due to intensifying competition to a slight recovery in sales volume recently, against the backdrop of the renewed global spread of infections. - FY2021-Q2ReframedAnnual report
「In addition, at our subsidiary, materials for kits developed as an application of OLED materials generated a substantial increase in revenue after being adopted by multiple diagnostic kit manufacturers, but sales volume has recently declined because of intensifying competition.」
Although the substantial increase in revenue from adoption by multiple manufacturers continued, the company also reported a recent decline in sales volume due to intensifying competition, describing the coexistence of the successful adoption and declining sales. - FY2021-Q1AdvancedAnnual report
「In addition, our subsidiary successfully developed materials for PCR diagnostic kits as an application of OLED materials. Their adoption by multiple diagnostic kit manufacturers resulted in a substantial increase in revenue and made a significant contribution to profit.」
Adoption of the materials for PCR diagnostic kits by multiple manufacturers was reflected in business performance, with a substantial increase in revenue and a contribution to profit reported. - FY2020First statedAnnual report
「Meanwhile, while our subsidiary was exploring applications for OLED materials, it successfully developed materials for diagnostic kits applicable to the PCR diagnostic method. The materials were adopted by multiple diagnostic kit manufacturers and consequently came to be used for diagnosing COVID-19.」
The company reported a new development and application achievement in which materials for PCR diagnostic kits were developed from applications for OLED materials and adopted by multiple diagnostic kit manufacturers.